Bradley L Campbell Amicus Therapeutics, Inc. (FOLD) insider trading activity

Bradley L Campbell is President and CEO of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 886,654 shares of FOLD, which is worth approximately $8.75 Million. The most recent transaction as insider was on Jun 01, 2023, when has been sold 11,700 shares (Common Stock) at a price of $2.7 per share, resulting in proceeds of $31,590. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 887K

0% 3M change

11.93% 12M change

Total Value Held $8.75 Million

Bradley L Campbell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 01 2023	BUY Exercise of conversion of derivative security	$31,590 $2.7 p/Share	11,700 Added 1.38%	835,154 Common Stock
May 01 2023	SELL Open market or private sale	$138,060 $11.8 p/Share	11,700 Reduced 1.4%	823,454 Common Stock
May 01 2023	BUY Exercise of conversion of derivative security	$28,665 $2.45 p/Share	11,700 Added 1.38%	835,154 Common Stock
Apr 03 2023	SELL Open market or private sale	$131,157 $11.21 p/Share	11,700 Reduced 1.4%	823,454 Common Stock
Apr 03 2023	BUY Exercise of conversion of derivative security	$28,665 $2.45 p/Share	11,700 Added 1.38%	835,154 Common Stock
Mar 15 2023	SELL Payment of exercise price or tax liability	$152,876 $11.43 p/Share	13,375 Reduced 1.6%	823,454 Common Stock
Mar 01 2023	SELL Open market or private sale	$268,000 $13.4 p/Share	20,000 Reduced 2.33%	836,829 Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	$28,665 $2.45 p/Share	11,700 Added 1.35%	856,829 Common Stock
Feb 01 2023	SELL Open market or private sale	$259,600 $12.98 p/Share	20,000 Reduced 2.31%	845,129 Common Stock
Feb 01 2023	BUY Exercise of conversion of derivative security	$28,665 $2.45 p/Share	11,700 Added 1.33%	865,129 Common Stock
Jan 11 2023	SELL Payment of exercise price or tax liability	$602,766 $12.02 p/Share	50,147 Reduced 5.55%	853,429 Common Stock
Jan 11 2023	BUY Grant, award, or other acquisition	-	98,040 Added 9.79%	903,576 Common Stock
Jan 09 2023	SELL Open market or private sale	$133,731 $11.43 p/Share	11,700 Reduced 1.43%	805,536 Common Stock
Jan 09 2023	BUY Exercise of conversion of derivative security	$28,665 $2.45 p/Share	11,700 Added 1.41%	817,236 Common Stock
Jan 04 2023	SELL Payment of exercise price or tax liability	$85,340 $12.03 p/Share	7,094 Reduced 0.87%	805,536 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$227,242 $11.93 p/Share	19,048 Reduced 2.29%	812,630 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	169,635 Added 16.94%	831,678 Common Stock
Jan 02 2023	SELL Payment of exercise price or tax liability	$336,690 $12.21 p/Share	27,575 Reduced 4.0%	662,043 Common Stock
Dec 01 2022	SELL Open market or private sale	$66,917 $12.2 p/Share	5,485 Reduced 0.79%	689,618 Common Stock
Dec 01 2022	BUY Exercise of conversion of derivative security	$19,362 $3.53 p/Share	5,485 Added 0.78%	695,103 Common Stock
Nov 01 2022	SELL Open market or private sale	$54,754 $10.01 p/Share	5,470 Reduced 0.79%	689,618 Common Stock
Nov 01 2022	BUY Exercise of conversion of derivative security	$19,309 $3.53 p/Share	5,470 Added 0.78%	695,088 Common Stock
Oct 03 2022	SELL Open market or private sale	$57,599 $10.53 p/Share	5,470 Reduced 0.79%	689,618 Common Stock
Oct 03 2022	BUY Exercise of conversion of derivative security	$19,309 $3.53 p/Share	5,470 Added 0.78%	695,088 Common Stock
Sep 01 2022	SELL Open market or private sale	$61,756 $11.29 p/Share	5,470 Reduced 0.79%	689,618 Common Stock

BLC

Bradley L Campbell

President and CEO

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account